Acoustic Cell Processing Helping to Industrialize Cell and Gene Therapy
A guest blog by Rui Tostoes, PhD, Vice President Bioprocessing, FloDesign Sonics In this article, acoustic cell processing, a unique platform technology that allows for the manipulation of cells with nearly shear-free and low power ultrasonic standing waves, is discussed with its application to cell and gene therapy manufacturing illustrated through case studies.
FloDesign Sonics’ Founder in Cell and Gene Therapy Insights Interview
Innovative technologies for CAR-T manufacturing: the key to commercialization
Investment Continues into FloDesign Sonics
Dynamk Capital, a life sciences venture capital fund, today announced an exciting new investment in advancing the commercial production of CAR T and immunotherapies by adding FloDesign Sonics to its growing portfolio. Dynamk's portfolio companies provide technologies and services that enable biopharmaceutical companies around the world to develop therapeutics faster and produce them more economically.
FloDesign Sonics Announces Co-Development Partnership and Availability of Pre-Commercial Acoustic Cell Processors to Early Adopters
FloDesign Sonics, Inc. (FDS), an innovator and developer of acoustic bioprocessing technologies, is pleased to announce a technology co-development deal with a large pharmaceutical corporation to commercialize acoustic-based unit operations in both concentration-wash and acoustic affinity cell separation (AACS). Under the terms of the deal, FDS will work with the customer’s CAR-T process development group to design, develop and deliver modular acoustic processing hardware for the two separate unit operations at multiple scales.
Pall Life Sciences bags BPI 2016 best downstream application award for Cadence Acoustic Separator System
Based on acoustic wave separation technology licensed from FloDesign Sonics, the Cadence Acoustic Separator was launched in early 2016 as a novel single-use solution for the clarification of cell culture bioprocess fluids.
FloDesign Sonics Adds Kevin Delbridge to Board of Directors
FloDesign Sonics Welcomes Kevin Delbridge to the Board of Directors and announces $18M Funding for Series A1 Round.
Pall Purchases Exclusive License to Cutting-Edge Acoustic Wave Separation Technology from FloDesign Sonics for Biopharm Application
PORT WASHINGTON, N.Y. – June 15, 2015 – Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, announced the signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications. The AWS technology enables very-high-efficiency continuous removal of the cells in a closed system without centrifugation, thereby streamlining a challenging step in the biologics manufacturing process within a small operating footprint. The technology will complement Pall's industry-leading STAXTM depth filtration products to enable continuous clarification of cell culture, enabling integration of the bioreactor with downstream processing.
FloDesign Sonics, Inc. Receives NSF Grant and Demonstrates Groundbreaking Work at the White House Water Summit
The White House Water Summit, held on United Nations World Water Day, addressed critical water issues facing the global community and focused attention on the vital work being done by innovative companies and organizations like FloDesign Sonics in order to sustainably secure access to the most precious natural resource.
Acoustic technique presents fresh take on water treatment
Technology could solve longstanding problem of separating suspended contaminants from water
FloDesign Sonics in Wilbraham licenses filtering technology to Pall Corporation
FloDesign Sonics, which is developing technology that uses sound vibrations to filter fluids including blood, has licensed that technology to industry giant Pall Corporation.
Wilbraham's FloDesign Sonics makes major medical breakthroughs using sound waves
Later this year, several pharmaceutical firms are planning to take delivery of a machine that could transform the industry.
FloDesign Sonics to launch device for biologic drugmaking this year
Stanley Kowalski, CEO of FloDesign Sonics, has taken to calling 2015 "the year of the product" for his Wilbraham company.
FloDesign Sonics gets $10 million to bring acoustics technology to new areas
On Thursday, FloDesign Sonics, based in Wilbraham, Mass., announced a $10 million Series A led by Bright Capital.
FloDesign Sonics using sound in bioprocessing raises $10M
FloDesign Sonics has gotten a $10 million investment led by Bright Capital.